The blood test that screens for Down syndrome during pregnancy is called noninvasive prenatal testing (NIPT), also known as cell-free DNA testing. This simple blood draw analyzes small fragments of fetal DNA circulating in the mother’s bloodstream to detect trisomy 21, the chromosomal condition responsible for Down syndrome. Today, NIPT remains the most accurate screening option available, with detection rates exceeding 99% for Down syndrome when performed after 10 weeks of gestation.
What Is a Blood Test for Down Syndrome?
NIPT is a prenatal screening test that examines cell-free fetal DNA (cffDNA) from the placenta. Unlike diagnostic tests such as amniocentesis or chorionic villus sampling (CVS), NIPT poses no risk of miscarriage because it requires only a maternal blood sample. It is recommended for all pregnancies, especially those with advanced maternal age, abnormal ultrasound findings, or a family history of chromosomal abnormalities.
How Does the Blood Test Work?
During pregnancy, a small percentage of the DNA in the mother’s blood comes from the placenta. NIPT sequences this cell-free DNA and counts the number of copies of each chromosome. An extra copy of chromosome 21 indicates a high likelihood of Down syndrome. The test can also screen for Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13), as well as sex chromosome aneuploidies.
Key Steps in NIPT
- Maternal blood draw (typically 10 mL) at or after 10 weeks of pregnancy.
- Laboratory analysis using next-generation sequencing or microarray technology.
- Results reported as “low risk” (negative) or “high risk” (positive) for each condition.
- Positive results require confirmatory diagnostic testing (amniocentesis or CVS).
When Is the Blood Test Performed?
NIPT is typically offered between 10 and 22 weeks of pregnancy, with optimal accuracy achieved after 10 weeks. Early testing (before 10 weeks) may yield insufficient fetal DNA, leading to inconclusive results. Today, many providers offer NIPT as early as 9 weeks with enhanced technology, but the standard window remains 10–13 weeks for first-trimester screening.
Accuracy and Reliability today
Modern NIPT has a sensitivity of >99% for Down syndrome and a specificity of >99.9%, meaning false positives are rare. However, no screening test is 100% perfect. Factors that can affect accuracy include maternal obesity, multiple gestations (twins/triplets), vanishing twin syndrome, and certain maternal conditions like cancer. Today, laboratories use advanced bioinformatics to minimize these confounders, but confirmatory testing is still recommended for high-risk results.
| Feature | NIPT (Screening) | Amniocentesis (Diagnostic) |
|---|---|---|
| Sample type | Maternal blood | Amniotic fluid |
| Risk to pregnancy | None | ~0.1–0.3% miscarriage risk |
| Accuracy for Down syndrome | >99% | >99.9% |
| Results time | 7–10 days | 10–14 days |
| When offered | From 10 weeks | 15–20 weeks |
Understanding Your Results
A “low risk” NIPT result means the chance of Down syndrome is very small, but not zero. A “high risk” result indicates an increased likelihood and warrants genetic counseling and diagnostic testing. Today, most laboratories provide a fetal fraction percentage (the proportion of fetal DNA in the sample) alongside results; a low fetal fraction may require a redraw. Always discuss results with your healthcare provider to determine next steps.
What Happens After a High-Risk Result?
If NIPT suggests Down syndrome, your doctor will likely recommend confirmatory testing through amniocentesis or CVS. These diagnostic tests analyze fetal cells directly and provide a definitive answer. Some women may also opt for a detailed ultrasound to look for physical markers associated with Down syndrome.
Insurance and Cost Considerations
In the United States, many insurance plans cover NIPT for women of advanced maternal age (35+), those with abnormal ultrasound findings, or those with a family history of chromosomal conditions. For women under 35 without risk factors, insurance coverage varies. Today, the out-of-pocket cost for NIPT typically ranges from $200 to $500, though some labs offer patient assistance programs. Check with your insurer and the testing laboratory before proceeding.
Take Control of Your Prenatal Health
Choosing the right blood test for Down syndrome during pregnancy is a personal decision that depends on your age, health history, and comfort with risk. NIPT offers a safe, accurate, and early screening option that can help you prepare for your baby’s arrival. At Women’s Health Labs, we provide reliable NIPT testing with fast turnaround and compassionate support. Order your NIPT test today to gain peace of mind and take the next step in your pregnancy journey.
Frequently asked questions
What blood test is used to screen for Down syndrome during pregnancy?
The blood test used is noninvasive prenatal testing (NIPT), also called cell-free DNA testing. It analyzes fetal DNA from the mother's blood to detect trisomy 21 (Down syndrome) with >99% accuracy.
How accurate is the blood test for Down syndrome today?
NIPT has a sensitivity of over 99% and a specificity of over 99.9% for Down syndrome. False positives are rare, but confirmatory diagnostic testing is recommended for high-risk results.
When should I get the blood test for Down syndrome during pregnancy?
NIPT is typically performed after 10 weeks of pregnancy, though some advanced tests can be done as early as 9 weeks. The optimal window is between 10 and 13 weeks for first-trimester screening.
Affiliate disclosure: Women's Health Labs may earn a commission when you book a test through links on this page, at no extra cost to you.